中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2001年
2期
162-164
,共3页
孔祥田%曾荔%宓培%夏同礼%刘玉立%郭应禄
孔祥田%曾荔%宓培%夏同禮%劉玉立%郭應祿
공상전%증려%복배%하동례%류옥립%곽응록
肾肿瘤/病理学%肾肿瘤/诊断
腎腫瘤/病理學%腎腫瘤/診斷
신종류/병이학%신종류/진단
目的研究肾集合管癌的临床病理特征。方法回顾性研究肾集合管癌的临床及病理资料并进行随访。结果 10例肾集合管癌占肾癌的2.1%。主要症状为血尿、腰腹痛。9例行肾癌根治术,1例行肿瘤剜除术。肿瘤主要位于肾髓质,呈灰白色或淡黄色,侵袭性生长;以腺管乳头状结构为主,部分混有肉瘤样癌、腺样囊性癌、条索及巢状癌。Fuhrman病理分级:G2, 1例;G3, 4例;G4, 5例。TNM综合病理分期:Ⅰ期4例,Ⅱ期2例,Ⅲ期1例,Ⅳ期3例。6例死于肾癌转移,其中1例术后19个月死于心脏病;2例无瘤生存;1例失访。平均生存时间13.3个月。结论肾集合管癌临床症状明显,临床病理分期高,进展快。主要治疗方法为肾癌根治术,多数病例于术后数月发生转移或死亡。
目的研究腎集閤管癌的臨床病理特徵。方法迴顧性研究腎集閤管癌的臨床及病理資料併進行隨訪。結果 10例腎集閤管癌佔腎癌的2.1%。主要癥狀為血尿、腰腹痛。9例行腎癌根治術,1例行腫瘤剜除術。腫瘤主要位于腎髓質,呈灰白色或淡黃色,侵襲性生長;以腺管乳頭狀結構為主,部分混有肉瘤樣癌、腺樣囊性癌、條索及巢狀癌。Fuhrman病理分級:G2, 1例;G3, 4例;G4, 5例。TNM綜閤病理分期:Ⅰ期4例,Ⅱ期2例,Ⅲ期1例,Ⅳ期3例。6例死于腎癌轉移,其中1例術後19箇月死于心髒病;2例無瘤生存;1例失訪。平均生存時間13.3箇月。結論腎集閤管癌臨床癥狀明顯,臨床病理分期高,進展快。主要治療方法為腎癌根治術,多數病例于術後數月髮生轉移或死亡。
목적연구신집합관암적림상병리특정。방법회고성연구신집합관암적림상급병리자료병진행수방。결과 10례신집합관암점신암적2.1%。주요증상위혈뇨、요복통。9례행신암근치술,1례행종류완제술。종류주요위우신수질,정회백색혹담황색,침습성생장;이선관유두상결구위주,부분혼유육류양암、선양낭성암、조색급소상암。Fuhrman병리분급:G2, 1례;G3, 4례;G4, 5례。TNM종합병리분기:Ⅰ기4례,Ⅱ기2례,Ⅲ기1례,Ⅳ기3례。6례사우신암전이,기중1례술후19개월사우심장병;2례무류생존;1례실방。평균생존시간13.3개월。결론신집합관암림상증상명현,림상병리분기고,진전쾌。주요치료방법위신암근치술,다수병례우술후수월발생전이혹사망。
Objective To study the clinicopathologic characteristics of renal collecting duct carcinoma(CDC). Methods A retrospective study was done in 10 cases of CDC. Results Among 466 cases of renal cell carcinoma admitted in our Institute between January 1989 and June 30, 1999, 10(2.1%) cases of CDC were identified. Seven presented with gross hematuria and 3 with abdominal pain. Radical nephrectomy was done in 9 patients,enucleation of tumor in one. The primary tumor was located predominantly in the renal medulla. Histologic examination showed prominent tubular or tubulopapillary structures. Sarcomatoid carcinoma, cystadenocarcinoma, nests and cords of tumor cells in desmoplastic stroma were identified in some cases. High molecular weight cytokeratin 34 β E12 was positive in 8 cases and peanut agglutinin in 7 cases. According to Fuhrman′s nuclear grade, one was in G2, 4 were in G3 and 5 in G4. Six patients died of metastases within 3 to 23 months(mean 13.3 months), one died of heart disease with tumor free after 19 months, two survived with tumor free for 14 months and 39 months, respectively, one lost from follow-up. Conclusion CDC is a distinctive renal cell carcinoma with prominent clinical appearance and progressive clinical course.